← All stocks

Mineralys Therapeutics, Inc.

MLYS Net selling

CIK 0001933414 #1952 in the set updated 17 Sep 2026

Bought (12 mo)

$8.76M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$84.34M

$7.78M on a plan · $24.12M straight out of an exercise

Sold at will

$52.44M

7 of 81 sales

Net

−$75.57M

−$43.68M against sales at will

By person

13 insiders · 84 transactions

24.6×

Jon Congleton holds 24.6 times base salary in stock. $15.68M of shares against $636.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Jon Congleton last reported holding, valued at $25.98, the price Common Stock was last bought or sold at on the open market here, on 21 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Slingsby Brian Taylor

Director

—

$43.35M (1)

−$43.35M

7,910,038

8.95%

$205.48M

−8.5%

Congleton Jon

Chief Executive Officer

—

$14.91M (17)

−$14.91M

603,621

0.6828%

$15.68M

−33.8%

Rodman David Malcom

Chief Medical Officer

—

$14.41M (39) scheduled

−$14.41M

51,384

0.0581%

$1.33M

−60.2%

RA CAPITAL MANAGEMENT, L.P. entity

Director

$8.76M (2)

—

+$8.76M

5,825,521

6.59%

$151.33M

+95.6%

Levy Adam Scott

CFO and Secretary

—

$6.16M (12) scheduled

−$6.16M

48,538

0.0549%

$1.26M

−69.8%

Warren Eric

Chief Commercial Officer

—

$3.09M (3) scheduled

−$3.09M

38,400

0.0434%

$997.51K

0.0%

Gold Alexander M

Director

—

$1.58M (5) scheduled

−$1.58M

6,200

0.0070%

$161.06K

—

Karydas Daphne

Director

—

$839.80K (4) scheduled

−$839.80K

6,200

0.0070%

$161.06K

—

Samsara BioCapital GP, LLC entity

10% owner

—

5,674,916

6.42%

$147.42M

+11.8%

AKKARAJU SRINIVAS

Director

—

594,435

0.6724%

$15.44M

—

Ferguson James J. III

Chief Medical Officer

—

102,400

0.1158%

$2.66M

—

SBLENDORIO GLENN

Director

—

6,200

0.0070%

$161.06K

—

DiRocco Derek

Director

—

6,200

0.0070%

$161.06K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Rodman David Malcom

15 Jul 2026

Chief Medical Officer

Sold on a plan

6,349

$26.61

$168.95K

Congleton Jon

13 Jul 2026

Chief Executive Officer

Sold on a plan

10,700

$27.24

$291.44K

Congleton Jon

30 Jun 2026

Chief Executive Officer

Sold on a plan

17,000

$26.82

$455.90K

Congleton Jon

30 Jun 2026

Chief Executive Officer

Sold on a plan

58,000

$25.94

$1.50M

Rodman David Malcom

15 Apr 2026

Chief Medical Officer

Sold on a plan

6,348

$27.66

$175.59K

Congleton Jon

13 Apr 2026

Chief Executive Officer

Sold on a plan

15,730

$26.83

$421.98K

Congleton Jon

31 Mar 2026

Chief Executive Officer

Sold on a plan

453

$27.05

$12.25K

Congleton Jon

31 Mar 2026

Chief Executive Officer

Sold on a plan

55,183

$26.54

$1.46M

Congleton Jon

31 Mar 2026

Chief Executive Officer

Sold on a plan

19,364

$25.50

$493.79K

Rodman David Malcom

14 Jan 2026

Chief Medical Officer

Sold on a plan

11,367

$32.61

$370.64K

Levy Adam Scott

12 Jan 2026

CFO and Secretary

Sold on a plan

10,758

$32.14

$345.72K

Congleton Jon

12 Jan 2026

Chief Executive Officer

Sold on a plan

7,117

$33.15

$235.93K

Congleton Jon

12 Jan 2026

Chief Executive Officer

Sold on a plan

9,119

$32.21

$293.71K

Rodman David Malcom

15 Oct 2025

Chief Medical Officer

Sold on a plan

10,369

$43.01

$445.98K

Congleton Jon

13 Oct 2025

Chief Executive Officer

Sold on a plan

1,552

$43.03

$66.78K

Congleton Jon

13 Oct 2025

Chief Executive Officer

Sold on a plan

13,548

$42.63

$577.54K

Levy Adam Scott

13 Oct 2025

CFO and Secretary

Sold on a plan

3,392

$42.26

$143.33K

Levy Adam Scott

13 Oct 2025

CFO and Secretary

Sold on a plan

7,366

$41.90

$308.65K

Show all 84 transactions →

Mineralys Therapeutics, Inc.

By person

Individual transactions

What was left out